Atlas Trials

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Clinical trial NCT00660387 · COMPLETED

Trial details

NCT number
NCT00660387
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Parkinson's Disease
Start date
2009-12-01
Primary completion
2011-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.